Bodycote (OTCMKTS:BYPLF) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Bodycote (OTCMKTS:BYPLF) from a sell rating to a hold rating in a report released on Monday morning, Zacks.com reports.

According to Zacks, “Bodycote PLC provides thermal processing services through heat treatment, metal joining, surface technology and Hot Isostatic Pressing. It serves aerospace, defense, automotive, power generation, oil & gas, construction, medical and transportation industry. Bodycote PLC is headquartered in Macclesfield, the United Kingdom. “

Shares of OTCMKTS:BYPLF remained flat at $$10.40 during trading on Monday. 1,100 shares of the stock traded hands. The company has a current ratio of 0.92, a quick ratio of 0.84 and a debt-to-equity ratio of 0.10. Bodycote has a twelve month low of $9.35 and a twelve month high of $12.10. The company has a 50-day moving average of $10.55 and a 200 day moving average of $10.56.

About Bodycote

Bodycote plc provides thermal processing services worldwide. The company operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and Hot isostatic pressing (HIP) services, including HIP product fabrication, isostatic pressing, and HIP supporting services.

Featured Story: Different Options Trading Strategies

Get a free copy of the Zacks research report on Bodycote (BYPLF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.